
    
      Estimated enrollment:

      Phase I: 60 Phase II: 53

      Study start Date: August 2013 Estimated study completion date: March 2016

      Treatment:

      Gembrax: albumin-bound paclitaxel over 30 minutes IV followed by Gemcitabine 10mg/mÂ²/min IV
      on day 1, 8 and 15 followed by 2 weeks of rest Folfirinox: Oxaliplatin IV associated with
      LeucovorinIV. After the end of leucovorin administration, bolus injection of 5FU and
      subsequent continuous 5FU 46-hour infusion at day 29 and 43.

      Day 1=Day 57
    
  